IL139587A0 - Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty - Google Patents

Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Info

Publication number
IL139587A0
IL139587A0 IL13958799A IL13958799A IL139587A0 IL 139587 A0 IL139587 A0 IL 139587A0 IL 13958799 A IL13958799 A IL 13958799A IL 13958799 A IL13958799 A IL 13958799A IL 139587 A0 IL139587 A0 IL 139587A0
Authority
IL
Israel
Prior art keywords
ghs
serm
selective
growth hormone
estrogen receptor
Prior art date
Application number
IL13958799A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL139587A0 publication Critical patent/IL139587A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL13958799A 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty IL139587A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IL139587A0 true IL139587A0 (en) 2002-02-10

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13958799A IL139587A0 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Country Status (29)

Country Link
EP (1) EP1085867A1 (xx)
JP (1) JP2002518328A (xx)
KR (1) KR20010052817A (xx)
CN (1) CN1305378A (xx)
AP (1) AP9901581A0 (xx)
AR (1) AR018868A1 (xx)
AU (1) AU3342099A (xx)
BG (1) BG105128A (xx)
BR (1) BR9911357A (xx)
CA (1) CA2335112A1 (xx)
CO (1) CO5070586A1 (xx)
EA (1) EA200001189A1 (xx)
GT (1) GT199900083A (xx)
HR (1) HRP20000857A2 (xx)
HU (1) HUP0102395A2 (xx)
ID (1) ID26726A (xx)
IL (1) IL139587A0 (xx)
IS (1) IS5727A (xx)
MA (1) MA26648A1 (xx)
NO (1) NO20006381D0 (xx)
OA (1) OA11569A (xx)
PA (1) PA8472101A1 (xx)
PE (1) PE20000633A1 (xx)
PL (1) PL345064A1 (xx)
SK (1) SK18902000A3 (xx)
TN (1) TNSN99118A1 (xx)
UY (1) UY25557A1 (xx)
WO (1) WO1999065488A1 (xx)
ZA (1) ZA993973B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
DK1460969T3 (da) * 2001-11-29 2008-09-01 Gtx Inc Forebyggelse og behandling af ved androgen-berövelse fremkaldt osteoporose
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
AP9901581A0 (en) 1999-06-30
CN1305378A (zh) 2001-07-25
EP1085867A1 (en) 2001-03-28
CO5070586A1 (es) 2001-08-28
BR9911357A (pt) 2001-03-13
HUP0102395A2 (hu) 2001-11-28
AR018868A1 (es) 2001-12-12
AU3342099A (en) 2000-01-05
ID26726A (id) 2001-02-01
PE20000633A1 (es) 2000-07-26
HRP20000857A2 (en) 2001-10-31
OA11569A (en) 2004-07-01
UY25557A1 (es) 2001-01-31
EA200001189A1 (ru) 2001-06-25
NO20006381L (no) 2000-12-14
PL345064A1 (en) 2001-11-19
CA2335112A1 (en) 1999-12-23
GT199900083A (es) 2000-12-05
PA8472101A1 (es) 2000-09-29
JP2002518328A (ja) 2002-06-25
TNSN99118A1 (fr) 2005-11-10
SK18902000A3 (sk) 2001-12-03
KR20010052817A (ko) 2001-06-25
WO1999065488A1 (en) 1999-12-23
BG105128A (en) 2001-11-30
IS5727A (is) 2000-11-24
ZA993973B (en) 2000-12-15
MA26648A1 (fr) 2004-12-20
NO20006381D0 (no) 2000-12-14

Similar Documents

Publication Publication Date Title
IL145937A0 (en) Methods and apparatus for secure distribution of software
GB9601049D0 (en) Methods of and apparatus for forming nozzles
HUP0104993A3 (en) Method and device for controlled delivery of active agents
EP1003450A4 (en) METHOD AND DEVICE FOR INDUCING HYPOTHERMY
HUP0102951A3 (en) Apparatus for treatment of meniere's disease and similar conditions
PL336701A1 (en) Treatment of central nervous system diseases using selective modulators of oestrogen receptors
PL344981A1 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
PL345064A1 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
GB2326358B (en) Improved positioning device for concave of cone crusher
PL345588A1 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
HUP0003340A3 (en) Process and apparatus for preparation of vesicles
GB9913560D0 (en) Mixing apparatus and method of mixing
PL336422A1 (en) Method of and apparatus for preparing asphalt mixes
DK0931454T3 (da) Apparat til findeling og blanding af foderkomponenter til dyrefoder
GB2319519B (en) Adjustment of mosaic spread for HOPG material
IL117770A0 (en) Method and apparatus for growing of extended crystals
GB9717211D0 (en) Improvements relating to means of controlling different apparatus
PL335477A1 (en) Method of and apparatus for controlling operation of snow removing mixture spreader
GB9817579D0 (en) Method of and apparatus for controlling headway
HUP9801165A3 (en) Process and apparatus for fire-prevention of cable-lines and this protekted cable-line
GB9908411D0 (en) Method and apparatus for controlled distribution of supports in combinatorial synthesis
IL132369A0 (en) Method of treatment of scalp and hair and formulations for implementation of this method
PL337444A1 (en) Method of and apparatus for meteringly dispensing predetermined portions of material
TW362757U (en) Improvement for protection apparatus of water heater
AU5084798A (en) Curing of orthopedic casting material and device and method for using same